|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of sales | |||||
| Gross Profit | |||||
| Research and development | |||||
| Marketing, selling and administrative | |||||
| Amortization of intangible assets | |||||
| Asset impairment, restructuring and other special charges | |||||
| Goodwill impairment | |||||
| Gain on divestiture | |||||
| Interest expense, net of capitalized interest | |||||
| Other expense, net | |||||
| Total other significant segment expenses | |||||
| (Loss) income before income taxes | |||||
| Income tax expense | |||||
| Net (loss) income | |||||
| (Loss) earnings per share: | |||||
| Basic (usd per share) | |||||
| Diluted (usd per share) | |||||
| Weighted-average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
